Combined treatment in punctate inner choroidopathy

Barbara Terelak-Borys, Katarzyna Zagajewska, Irmina Jankowska-Lech, Piotr Tesla, Iwona Grabska-Liberek Department of Ophthalmology, Centre of Postgraduate Medical Education, Prof W Orlowski Clinical Hospital, Warsaw, Poland Purpose: The purpose of this study was to describe a combination treatment...

Full description

Bibliographic Details
Main Authors: Terelak-Borys B, Zagajewska K, Jankowska-Lech I, Tesla P, Grabska-Liberek I
Format: Article
Language:English
Published: Dove Medical Press 2016-09-01
Series:Therapeutics and Clinical Risk Management
Subjects:
Online Access:https://www.dovepress.com/combined-treatment-in-punctate-inner-choroidopathy-peer-reviewed-article-TCRM
id doaj-9215f38f0f314005872679444871ec74
record_format Article
spelling doaj-9215f38f0f314005872679444871ec742020-11-24T23:07:42ZengDove Medical PressTherapeutics and Clinical Risk Management1178-203X2016-09-01Volume 121467147129107Combined treatment in punctate inner choroidopathyTerelak-Borys BZagajewska KJankowska-Lech ITesla PGrabska-Liberek IBarbara Terelak-Borys, Katarzyna Zagajewska, Irmina Jankowska-Lech, Piotr Tesla, Iwona Grabska-Liberek Department of Ophthalmology, Centre of Postgraduate Medical Education, Prof W Orlowski Clinical Hospital, Warsaw, Poland Purpose: The purpose of this study was to describe a combination treatment for choroidal neovascular (CNV) membrane, secondary to punctate inner choroidopathy (PIC).Patient and methods: A 44-year-old female patient was diagnosed with PIC complicated by the development of recurrent juxtafoveal neovascular membrane. The treatment included a sequence of monotherapy regimens: systemic steroid therapy, photodynamic therapy, and intravitreal injections of vascular endothelial growth factor (VEGF) inhibitor (anti-VEGF). Owing to the CNV membrane resistance to various types of monotherapy, a combination treatment consisting of local injections of steroid underneath the Tenon’s capsule and intravitreal anti-VEGF injections was used.Results: Systemic steroid therapy resulted in rapid local improvement with a very short remission period. No positive effects of photodynamic therapy were observed. Sequential anti-VEGF injections led to remission periods of several months. Permanent regression of CNV membrane was achieved following combined local application of steroid and intravitreal anti-VEGF injections.Conclusion: A combination treatment including steroid and anti-VEGF medication characterized by anti-inflammatory and antiangiogenic effects may be a very beneficial option for the treatment of recurrent CNV membrane as a complication of PIC. Keywords: punctate inner choroidopathy, neovascular membrane, anti-VEGF injections, photodynamic therapy, steroidshttps://www.dovepress.com/combined-treatment-in-punctate-inner-choroidopathy-peer-reviewed-article-TCRMpunctate inner choroidopathyneovascular membraneanti-VEGF injectionsphotodynamic therapysteroids
collection DOAJ
language English
format Article
sources DOAJ
author Terelak-Borys B
Zagajewska K
Jankowska-Lech I
Tesla P
Grabska-Liberek I
spellingShingle Terelak-Borys B
Zagajewska K
Jankowska-Lech I
Tesla P
Grabska-Liberek I
Combined treatment in punctate inner choroidopathy
Therapeutics and Clinical Risk Management
punctate inner choroidopathy
neovascular membrane
anti-VEGF injections
photodynamic therapy
steroids
author_facet Terelak-Borys B
Zagajewska K
Jankowska-Lech I
Tesla P
Grabska-Liberek I
author_sort Terelak-Borys B
title Combined treatment in punctate inner choroidopathy
title_short Combined treatment in punctate inner choroidopathy
title_full Combined treatment in punctate inner choroidopathy
title_fullStr Combined treatment in punctate inner choroidopathy
title_full_unstemmed Combined treatment in punctate inner choroidopathy
title_sort combined treatment in punctate inner choroidopathy
publisher Dove Medical Press
series Therapeutics and Clinical Risk Management
issn 1178-203X
publishDate 2016-09-01
description Barbara Terelak-Borys, Katarzyna Zagajewska, Irmina Jankowska-Lech, Piotr Tesla, Iwona Grabska-Liberek Department of Ophthalmology, Centre of Postgraduate Medical Education, Prof W Orlowski Clinical Hospital, Warsaw, Poland Purpose: The purpose of this study was to describe a combination treatment for choroidal neovascular (CNV) membrane, secondary to punctate inner choroidopathy (PIC).Patient and methods: A 44-year-old female patient was diagnosed with PIC complicated by the development of recurrent juxtafoveal neovascular membrane. The treatment included a sequence of monotherapy regimens: systemic steroid therapy, photodynamic therapy, and intravitreal injections of vascular endothelial growth factor (VEGF) inhibitor (anti-VEGF). Owing to the CNV membrane resistance to various types of monotherapy, a combination treatment consisting of local injections of steroid underneath the Tenon’s capsule and intravitreal anti-VEGF injections was used.Results: Systemic steroid therapy resulted in rapid local improvement with a very short remission period. No positive effects of photodynamic therapy were observed. Sequential anti-VEGF injections led to remission periods of several months. Permanent regression of CNV membrane was achieved following combined local application of steroid and intravitreal anti-VEGF injections.Conclusion: A combination treatment including steroid and anti-VEGF medication characterized by anti-inflammatory and antiangiogenic effects may be a very beneficial option for the treatment of recurrent CNV membrane as a complication of PIC. Keywords: punctate inner choroidopathy, neovascular membrane, anti-VEGF injections, photodynamic therapy, steroids
topic punctate inner choroidopathy
neovascular membrane
anti-VEGF injections
photodynamic therapy
steroids
url https://www.dovepress.com/combined-treatment-in-punctate-inner-choroidopathy-peer-reviewed-article-TCRM
work_keys_str_mv AT terelakborysb combinedtreatmentinpunctateinnerchoroidopathy
AT zagajewskak combinedtreatmentinpunctateinnerchoroidopathy
AT jankowskalechi combinedtreatmentinpunctateinnerchoroidopathy
AT teslap combinedtreatmentinpunctateinnerchoroidopathy
AT grabskalibereki combinedtreatmentinpunctateinnerchoroidopathy
_version_ 1716362343374389248